Top 200 Drug Matching Game

30
Top 200 Drug Matching Game
Top 200 Drug Matching Game is an iOS app from Christopher Whitehead in the News category, currently rated 2.5★ across 10 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 30: Emerging (early traction worth watching). For a News app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
📊 Performance Tracking LIVE
💰 Forecast Revenue / mo
MODEL| Paid app ($5.99)METRIC | +$2,800 | |
| Below-average rating (2.5★)METRIC | −$1,500 | |
| Mature app (10y old)METRIC | +$1,500 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (10 ratings)METRIC | −$300 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v4.0.0
- Quiz mode, learned stars and text size options
- My Top 240: swap in any drug to build your own list
- Switch between the New (2026) and Previous (2024) lists
- Drug lists fully editable… Full release notes →
Profile & Insights
Identification
- App name
- Top 200 Drug Matching Game
- Developer
- Christopher Whitehead
- Bundle ID
- Not found
- App Store URL
- Open in App Store
- Category
- News
- Content rating
- 4+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $1.4K/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth0 ratings+-100% lifetimeShow 3-year history estimate ▾
📝 About this app
NEW FOR 2026
The Top 240 has been updated to follow the latest list of the most prescribed drugs, with 37 new drugs including Mounjaro, Ozempic, Entresto, Farxiga and Trelegy Ellipta. Prefer the drugs you already studied? Switch back to the Previous (2024) list anytime.
Each round shows a drug name and picture. Tap its match from 20 answer tiles until every drug is matched. Play Brand-to-Generic or Generic-to-Brand to learn the names both ways.
GAME MODES… View full description on the official store →
What Worked™ · Development Pipeline
9 EVENTS TRACKEDTrack this app’s revenue
FREESynthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ News complexity ×1.20 | +$10K |
| ⚙ 10.5y maintenance × ~1-person team | +$62K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| 📅 10.5y proven track record | +20% |
| ⭐ ★ rating < 3.5 (weak) | -18% |
| 🏷 News category multiple | -5% |
| ⭐ Small user base (<1K ratings) | -8% |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 📦 App bundle size | 41 MB |
| 🏷 Category context | News |
| 📦 Small-mid iOS bundle | → Native Swift / UIKit (pre-2020 era) |
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
| 📅 32 days since last update | Healthy release cadence |
| 👥 Small user base (10 ratings) + 10.5y old | +10% (solo-project pattern) |
📝 Description
95
Why low confidence: only 10 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Top 200 Drug Matching Game is a early-stage iOS app in the news space with weak public traction — only 10 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
